Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02119676
Title Study of Ruxolitinib in Colorectal Cancer Patients
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Incyte Corporation
Indications
Therapies
Age Groups: adult
Covered Countries USA | ISR | GBR | FRA | ESP | DEU | AUS

Facility Status City State Zip Country Details
Chandler Arizona United States Details
Gilbert Arizona United States Details
Mesa Arizona United States Details
Scottsdale Arizona United States Details
Los Angeles California United States Details
Pasadena California United States Details
Santa Barbara California United States Details
Aurora Colorado United States Details
Colorado Springs Colorado United States Details
Denver Colorado United States Details
Altamonte Springs Florida United States Details
Miami Florida United States Details
Ocala Florida United States Details
Orlando Florida United States Details
Tampa Florida United States Details
Niles Illinois United States Details
Lafayette Indiana United States Details
Ames Iowa United States Details
New Orleans Louisiana United States Details
Baltimore Maryland United States Details
Jefferson City Missouri United States Details
Saint Louis Missouri United States Details
Lincoln Nebraska United States Details
Omaha Nebraska United States Details
Henderson Nevada United States Details
Las Vegas Nevada United States Details
Albany New York United States Details
Binghamton New York United States Details
Bronx New York United States Details
Hudson New York United States Details
Johnson City New York United States Details
New York New York United States Details
Canton Ohio United States Details
Cincinnati Ohio United States Details
Portland Oregon United States Details
Charleston South Carolina United States Details
Easley South Carolina United States Details
Greenville South Carolina United States Details
Greer South Carolina United States Details
Sumter South Carolina United States Details
Chattanooga Tennessee United States Details
Nashville Tennessee United States Details
Arlington Texas United States Details
El Paso Texas United States Details
Fort Worth Texas United States Details
Houston Texas United States Details
Paris Texas United States Details
Plano Texas United States Details
Tyler Texas United States Details
American Fork Utah United States Details
Bountiful Utah United States Details
Murray Utah United States Details
Provo Utah United States Details
Salt Lake City Utah United States Details
West Jordan Utah United States Details
Roanoke Virginia United States Details
Vancouver Washington United States Details
Bentleigh East Australia Details
Herston Australia Details
Kurralta Park Australia Details
New Lambton Heights Australia Details
Randwick Australia Details
Avignon Cedex 09 France Details
Besançon France Details
Le Mans France Details
Lille France Details
Marseille Cedex 05 France Details
Paris France Details
Augsburg Germany Details
Halle Germany Details
Hamburg Germany Details
Beer Sheva Israel Details
Haifa Israel Details
Petah Tikva Israel Details
Ramat Gan Israel Details
Tel Aviv Israel Details
Soeul Korea, Republic of Details
Oviedo Asturias Spain Details
Barcelona Spain Details
Madrid Spain Details
Sevilla Spain Details
Valencia Spain Details
Birmingham United Kingdom Details
Bournemouth United Kingdom Details
London United Kingdom Details
Sutton United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field